AI designs new drugs based on protein structures

“It’s a real breakthrough for drug discovery”: Process ensures right from the start that the molecules can be chemically synthesised

25-Apr-2024 - A new computer process developed by chemists at ETH Zurich makes it possible to generate active pharmaceutical ingredients quickly and easily based on a protein’s three-​dimensional surface. The new process could revolutionise drug research. “It’s a real breakthrough for drug discovery,” says ...

SUANFARMA announces a collaboration with Reyoung Pharmaceutical

The main objective of the collaboration is to introduce generic pharmaceutical ingredients to the market for the treatment of infectious diseases

19-Oct-2023 - SUANFARMA, through its R&D division, celebrates the historic agreement reached with Reyoung Pharmaceutical, a leader in the manufacture of active ingredients since 1966. Reyoung´s decades of experience as an exporter of products worldwide are perfectly aligned with SUANFARMA, which has been ...

Green chemistry: BAM investigates pharmaceutical production without solvents and CO₂ emissions

Pharmaceutical production with mechanochemistry

28-Nov-2022 - The Bundesanstalt für Materialforschung und -prüfung (BAM) is developing a more sustainable process to produce active pharmaceutical ingredients in a major EU project: The pilot project is intended to demonstrate the advantages of mechanochemistry for more environmentally friendly and CO2-neutral ...

More Sustainability with Mechanochemistry

Research project will develop new environmentally friendly methods for manufacturing active pharmaceutical ingredients using mechanochemistry as a disruptive technology

29-Sep-2022 - Flour, coffee or spices: Many people know the principle of a mill from the kitchen. But special mills are also used for research purposes in the laboratories of the Max-Planck-Institut für Kohlenforschung. The scientists are convinced that mechanochemistry can make the chemical industry more ...

Merck Opens €59 Million CDMO Facility to Address Demand for Critical Cancer Therapies

Expansion doubles production of the most highly potent active pharmaceutical ingredients (HPAPIs)

27-Jun-2022 - Merck announced that its Life Science business sector has doubled its high-potent active pharmaceutical ingredients (HPAPI) production capacity with the expansion of its facility in Verona, near Madison, Wisconsin, USA. This new €59 million, 70,000 square foot facility, officially opened, brings ...

METiS Joins the Roche Accelerator

Start-up combines cutting-edge AI data-driven algorithms, mechanism-driven quantum mechanics and molecular dynamics simulations

23-May-2022 - METiS announced officially joining the Roche Accelerator with the goal to tap into Roche’s global scientific expertise, laboratory facilities and foster collaboration discussions on formulation development and optimization with Roche Innovation Center Shanghai. "We are excited to become a member ...

Heraeus expands capacity for platinum-based active pharmaceutical ingredients to treat cancer

12-Aug-2021 - Heraeus has significantly built up its manufacturing capacity for active pharmaceutical ingredients to fight cancer. The company announced that its new production line for platinum-based pharmaceutical ingredients located at its headquarters in Hanau is now running at full speed, and customers ...

Active pharmaceutical ingredients can persist in the environment

26-Jul-2019 - Homeowners who rely on private wells as their drinking water source can be vulnerable to bacteria, nitrates, and other contaminants that have known human health risks. Because they are not connected to a public drinking water supply, the homeowners are responsible for ensuring that their own ...

Biesterfeld Spezialchemie: New business unit combines healthcare distribution activities

19-Oct-2017 - As part of its ongoing drive to develop market segment focus, Biesterfeld Spezialchemie is creating a new business unit for healthcare distribution. This move is a logical continuation of previous developments and will allow the distributor to effectively target this highly demanding market. “The ...

Eurofins acquires biopharmaceutical company Alphora Research, Inc.

14-Jun-2017 - Eurofins Scientific announces the acquisition of Alphora Research Inc., a full service contract research, development and manufacturing organization (CRDMO) for complex and niche small molecule active pharmaceutical ingredients (APIs), based in Mississauga, Ontario, Canada. Alphora has ...